Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000647296 | SCV000769085 | uncertain significance | Brugada syndrome 6 | 2017-10-27 | criteria provided, single submitter | clinical testing | This sequence change disrupts the translational stop signal of the KCNE3 mRNA. It is expected to extend the length of the KCNE3 protein by 62 additional amino acid residues. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with KCNE3-related disease. Experimental studies and prediction algorithms are not available for this variant, and the functional significance of the additional amino acids are currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |